Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension

Parkinsonism and Related Disorders

Volumn 15, Issue 2, 2009, Pages 122-127

  Imrich, Richard ^a   Eldadah, Basil A ^a   Bentho, Oladi ^a   Pechnik, Sandra ^a   Sharabi, Yehonatan ^b   Holmes, Courtney ^a   Grossman, Ehud ^b   Goldstein, David S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Parkinson disease; Pre ejection period; Pure autonomic failure; Sympathetic denervation

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ISOPRENALINE; TYRAMINE;

AGED; ARTICLE; ATROPHY; AUTONOMIC DENERVATION; CHRONOTROPISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART DENERVATION; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART PREEJECTION PERIOD; HEART RATE; HUMAN; INOTROPISM; MALE; NEUROGENIC ORTHOSTATIC HYPOTENSION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC TIME INTERVAL;

ADRENERGIC BETA-AGONISTS; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; DOPAMINE; FEMALE; HEART; HEMODYNAMICS; HUMANS; HYPOTENSION, ORTHOSTATIC; ISOPROTERENOL; MALE; METHOXYHYDROXYPHENYLGLYCOL; NOREPINEPHRINE; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC; SYMPATHECTOMY; SYMPATHOMIMETICS; TYRAMINE;

EID: 58349097105     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.04.002     Document Type: Article

References (26)

1. Marti M.J., Tolosa E., and Campdelacreu J. Clinical overview of the synucleinopathies. Mov Disord 18 Suppl 6 (2003) S21-S27
2. 123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 53 (1999) 1020-1025
3. Goldstein D.S., Holmes C., Li S.T., Bruce S., Metman L.V., and Cannon III R.O. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133 (2000) 338-347
4. Takatsu H., Nishida H., Matsuo H., Watanabe S., Nagashima K., Wada H., et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 41 (2000) 71-77
5. Holmes C., Eisenhofer G., and Goldstein D.S. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653 (1994) 131-138
6. Weissler A.M., Harris W.S., and Schoenfeld C.D. Systolic time intervals in heart failure in man. Circulation 37 (1968) 149-159
7. Atkins C.E., and Snyder P.S. Systolic time intervals and their derivatives for evaluation of cardiac function. J Vet Intern Med 6 (1992) 55-63
8. Berntson G.G., Lozano D.L., Chen Y.J., and Cacioppo J.T. Where to Q in PEP. Psychophysiology 41 (2004) 333-337
9. Cacioppo J.T., Berntson G.G., Binkley P.F., Quigley K.S., Uchino B.N., and Fieldstone A. Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology 31 (1994) 586-598
10. Graboys T.B., Forlini Jr. F.J., and Michaelson E.D. Systolic time intervals during lower body negative pressure. J Appl Physiol 37 (1974) 329-332
11. Lewis R.P., Boudoulas H., Welch T.G., and Forester W.F. Usefulness of systolic time intervals in coronary artery disease. Am J Cardiol 37 (1976) 787-796
12. Randazzo A., Sardella F., Martinotti R., Daffara G., Parziale M., and Cremonesi G. Evaluation of systolic time intervals in patients with angina pectoris. Am Heart J 105 (1983) 756-762
13. Sutton R., Hodd Jr. W.P., and Koch G.G. Noninvasive assessment of left ventricular function in chronic heart disease. Am Heart J 93 (1977) 289-297
14. Schachinger H., Weinbacher M., Kiss A., Ritz R., and Langewitz W. Cardiovascular indices of peripheral and central sympathetic activation. Psychosom Med 63 (2001) 788-796
15. Goldstein D.S., Horwitz D., and Keiser H.R. Comparison of techniques for measuring baroreflex sensitivity in man. Circulation 66 (1982) 432-439
16. Bianchetti M.G., Minder I., Beretta-Piccoli C., Meier A., and Weidmann P. Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects. Klin Wochenschr 60 (1982) 465-470
17. Charkoudian N., Joyner M.J., Sokolnicki L.A., Johnson C.P., Eisenach J.H., Dietz N.M., et al. Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572 (2006) 821-827
18. Jacob G., Costa F., Vincent S., Robertson D., and Biaggioni I. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation 107 (2003) 2475-2479
19. Jacob G., Gamboa A., Diedrich A., Shibao C., Robertson D., and Biaggioni I. Tyramine-induced vasodilation mediated by dopamine contamination: a paradox resolved. Hypertension 46 (2005) 355-359
20. Meck J.V., Martin D.S., D'Aunno D.S., and Waters W.W. Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function. J Cardiovasc Pharmacol 41 (2003) 126-131
21. Holmes C., Moak J., Eldadah B., Zimmerly E., Sharabi Y., and Goldstein D.S. Dopamine contamination of infused tyramine. Clin Chem 51 (2005) 1733-1735
22. Friedman J.H., Brown R.G., Comella C., Garber C.E., Krupp L.B., Lou J.S., et al. Fatigue in Parkinson's disease: a review. Mov Disord 22 (2007) 297-308
23. Werner W.G., DiFrancisco-Donoghue J., and Lamberg E.M. Cardiovascular response to treadmill testing in Parkinson disease. J Neurol Phys Ther 30 (2006) 68-73
24. Polinsky R.J., Kopin I.J., Ebert M.H., and Weise V. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 31 (1981) 1-7
25. Davies B., Sudera D., Sagnella G., Marchesi-Saviotti E., Mathias C., Bannister R., et al. Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. J Clin Invest 69 (1982) 779-784
26. Majewski H. Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors. J Auton Pharmacol 3 (1983) 47-60